IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adlai Nortye LTD (ANL)

CUSIP: 00704R109 | US | Healthcare · Biotechnology | Small Cap | 54 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AVenrock Healthcare Capital Partners III, L.P.9,638,1934.4%Newly reportedJun 30, 2026No 13F filer matched
13G/ACormorant Asset Management, LP3,978,2296.8%New 5%+ stakeJun 30, 2026

Institutional Holders — Q3 2026

Antipodes Partners Ltd1,808
0.0% of portfolio›$28.9K
China Universal Asset Management Co., Ltd.1,600
0.0% of portfolio›$25.0K
Caitong International Asset Management Co., Ltd4
0.0% of portfolio›$64
StyleTurnoverLocationFiled
Antipodes Partners Ltd
1,808$28.9K0.0%ValueHighRoyal Exchange, China2026-11-05
China Universal Asset Management Co., Ltd.
1,600$25.0K0.0%GrowthMediumShanghai, France2026-10-28
Caitong International Asset Management Co., Ltd
4$640.0%GrowthVery HighHong Kong, South Korea2026-10-29
No 13F filer matched
13G/AVenrock Healthcare Capital Partners III, L.P.9,638,193
4.4% of class · Jun 30, 2026Newly reported
No 13F filer matched
13G/ACormorant Asset Management, LP3,978,229
6.8% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched